Biden’s Medicare drug price negotiations will leave pharma mostly unscathed: CBOnews2021-11-19T14:52:15+00:00November 19th, 2021|Fierce Pharma|
Fierce Pharma Asia—Biocon, Viatris’ insulin biosim launch; AstraZeneca China’s deceleration; Huahai’s FDA warning liftnews2021-11-19T12:26:56+00:00November 19th, 2021|Fierce Pharma|
NICE delays decision on Roche’s Evrysdi but will allow its use at a discounted pricenews2021-11-18T20:43:58+00:00November 18th, 2021|Fierce Pharma|
Biogen’s Aduhelm ‘likely’ linked to Alzheimer’s patient’s death, RBC analyst saysnews2021-11-18T20:21:27+00:00November 18th, 2021|Fierce Pharma|
Eli Lilly, under pressure from Biohaven, launches head-to-head migraine trial between Emgality and Nurtecnews2021-11-18T16:24:49+00:00November 18th, 2021|Fierce Pharma|
Johnson & Johnson expects 14 new blockbusters by the middle of the decade, execs saynews2021-11-18T15:47:32+00:00November 18th, 2021|Fierce Pharma|
Merck’s Keytruda opens new blockbuster frontier with FDA approval in post-surgery kidney cancernews2021-11-18T14:57:08+00:00November 18th, 2021|Fierce Pharma|
Bayer plans to stay the course amid investor pressure to split up, CEO saysnews2021-11-18T14:53:43+00:00November 18th, 2021|Fierce Pharma|
Pfizer inks $5.3B Paxlovid supply deal with US, adding to its huge pandemic revenue haulnews2021-11-18T13:14:58+00:00November 18th, 2021|Fierce Pharma|
Bayer teams with Syntegon to access new continuous manufacturing platformnews2021-11-18T13:03:57+00:00November 18th, 2021|Fierce Pharma|
